Document is current
Any future updates will be listed below
-
Authors
Chen, Naiyu
McGrath, Colleen B.
Stopsack, Konrad H.
Morgans, Alicia K.
Nethery, Rachel C.
Dickerman, Barbra A.
Mucci, Lorelei A.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R00 CA248335)
- License Information
-
More Information
Article History
Received: 19 March 2024
Accepted: 14 June 2024
First Online: 1 July 2024
Declarations
:
: The study protocol was approved by the institutional review board of Harvard T.H. Chan School of Public Health as well as those of participating registries as required.
: Written informed consent was obtained from all study participants.
: LAM received research funding (to Harvard University) from Astra Zeneca; was a consultant to Bayer Pharmaceuticals; and is on the Scientific Advisory Board and holds equity in Convergent Therapeutics. None of these disclosures are related to the current study. The other authors report no conflicts of interest.
